BRIEF published on 11/20/2024 at 14:59, 23 hours 8 minutes ago The Vanguard Group Discloses Significant Stake in Britvic plc Britvic Plc Takeover Code Vanguard Group Financial Disclosure Shareholding
PRESS RELEASE published on 11/20/2024 at 14:54, 23 hours 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses owning 5.47% of Britvic plc's 20p ordinary shares. Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Britvic Plc Rule 8.3 Takeover Code Vanguard Group
BRIEF published on 11/20/2024 at 08:05, 1 day 6 hours ago Britvic Plc Reports Robust Annual Results Amid Economic Challenges Revenue Growth Sustainability Initiatives Brand Expansion Britvic Financials Carlsberg Acquisition
PRESS RELEASE published on 11/20/2024 at 08:00, 1 day 6 hours ago Britvic plc Final Results Britvic plc reports strong financial results with a 9.5% increase in revenue and a 15.2% rise in adjusted EBIT for the year ending 30 September 2024. Operational highlights include robust demand for key brands and expansion in Brazil Financial Results Revenue Increase Britvic Plc Adjusted EBIT Brand Expansion
BRIEF published on 11/19/2024 at 15:23, 1 day 22 hours ago The Vanguard Group Discloses Stake in Britvic PLC Securities Britvic Plc Takeover Code Vanguard Group Stake Disclosure
PRESS RELEASE published on 11/19/2024 at 15:18, 1 day 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Britvic PLC The Vanguard Group, Inc. discloses ownership of 5.47% in Britvic PLC's 20p ordinary securities as of 18 Nov 2024 Securities Britvic Plc Vanguard Group Ownership Disclosure Public Disclosure
BRIEF published on 11/19/2024 at 13:04, 2 days 1 hour ago Britvic Directors Increase Shareholdings through Incentive Plan London Stock Exchange Share Incentive Plan Director Shareholding Market Regulation Britvic
PRESS RELEASE published on 11/19/2024 at 12:59, 2 days 1 hour ago Director/PDMR Shareholding Britvic plc directors purchase shares under SIP, Simon Litherland and Rebecca Napier buy 12 and 11 shares respectively. See full details in the announcement Shareholders Britvic Plc Stock Market Directors Financial Transaction
BRIEF published on 11/18/2024 at 17:13, 2 days 20 hours ago Britvic Plc Receives Notification on Major Shareholding Voting Rights Société Générale Shareholding Regulatory Notification Britvic
PRESS RELEASE published on 11/18/2024 at 17:08, 2 days 20 hours ago Holding(s) in Company Societe Generale notifies acquisition of 5.9493% voting rights in Britvic Plc (BVIC). Regulatory announcement regarding major shareholding notification Voting Rights Société Générale Britvic Plc BVIC Major Shareholding
Published on 11/21/2024 at 13:30, 37 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 37 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 32 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 52 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 9 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 47 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
